Navigation Links
New Diabetic Drugs More Effective than Older Ones

A new study suggests that patients on the newer medications for diabetics had a slightly lower risk of hospitalization//. They also spent between $920 and $1,760 less on annual total healthcare costs.

Rajesh Balkrishnan, the study’s lead author and the Merrell Dow professor of pharmacy at Ohio State University analyzed more than three years of medical records data on patients who took thiazolidinediones (TZDs) or either metformin or a sulfonylurea to control their diabetes. TZDs (pioglitazone and rosiglitazone, brand names Actos and Avandia, respectively), were approved by the Food and Drug Administration in the late 1990s. Metformin and sulfonylureas have been on the market for more than 50 years. TZD was the strongest predictor of a reduced risk of hospitalization and decreased healthcare costs in this group of patients. But TZDs can be 10 times more expensive than the older diabetes drugs.

Some of the newer drugs are more expensive but the extra expense is made up for by a reduction of cost in the healthcare aspect. The study is published in the journal Current Medical Research and Opinion. The researchers collected information on 3,191 adults enrolled in the North Carolina Medicaid program. All of the participants had Type 2 diabetes and started medications for the disease between July 2001 and December 2003.

The enrollees were divided into two groups based on the type of drug their physicians prescribed. About 1,774 took a TZD, while 1,417 took either metformin or a sulfonylurea. The researchers collected information on total healthcare expenditures and hospitalization rates for all patients. Type 2 diabetic patients are insulin resistant that is the cells in his body can’t correctly make use of the insulin and hence blood sugar levels remain high. TZDs make cells in the body more sensitive to insulin, while metformin lowers blood sugar levels and sulfonylureas boost pancreatic insulin production.

Balkrishnan said that a brand-name TZD may cost $100 a month, while a prescription for sulfonylurea or metformin may cost as little as $10 a month. Overall, the participants who took a TZD spent an average of $76 to $150 less per month on total healthcare costs. The patients who were prescribed TZDs were about 10 % less likely to be hospitalized than were the patients taking either of the other two older drugs.


'"/>




Related medicine news :

1. New Drug in Diabetic Neuropathy
2. Cinnamon May Help Diabetics
3. Eating disorder in Diabetic girls lead to eyesight damage.
4. Diabetic testing gets easier
5. Heart disease threat starts early in life for Diabetics
6. Diabetics and their babies
7. Beta-Carotene May Aid Diabetics
8. Diabetics prone to periodontitis
9. Blood Vessel Surgery Safe for Diabetics
10. Marriage does good for Diabetics
11. Niacin Safe for Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Gym Source, America’s leading retailer of ... at South Dixie Hwy in Miami, FL. , “We are elated to be opening ... innovative in-store concept is designed to give clients a seamless and motivating shopping experience.” ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... SunView Software’s ... Award for Innovation of the Year. , Each year, Pink Elephant recognizes ... an innovative approach to address a specific business problem or opportunity. The award highlights ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Mirror Mirror Beauty ... the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul ... of this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved ...
(Date:1/17/2017)... Houston, TEXAS (PRWEB) , ... January 17, 2017 ... ... solution provider, today announced its partnership with Sigfox in the U.S.A. ... to cities nationwide including new offerings on large-scale environmental sensor deployments such ...
(Date:1/17/2017)... ... 2017 , ... Seceon , the only threat detection ... announced a strategic partnership with TechLab Security, a leading Enterprise Systems ... Security has become a strategic partner and a value added reseller of Seceon’s ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Secretary of Health Dr. Karen Murphy ... are warning Pennsylvanians of the potentially lethal risks ... the drug in Beaver County . ... animals and is not meant for humans – it ... it," Secretary Murphy said. "It,s absolutely essential that first ...
(Date:1/17/2017)... 2017 Research and Markets has announced ... - 2024" report to their offering. ... This new report revisits the market ... was issued in May of 2015. Self-healing is an area of ... analysis we projected a market potential of $2.7 billion ($US) by ...
(Date:1/17/2017)... -- The Global Nebulizers Market is poised to grow ... decade to reach approximately $1698.68 million by 2025. Some ... include rapidly growing demand in emerging regions, increasing use ... and online marketing strategies by key players. ... pneumatic nebulizers, ultrasonic nebulizers and mesh nebulizers. Pneumatic nebulizers ...
Breaking Medicine Technology: